Study of Colchicine Resistance in Familial Mediterranean Fever

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

July 4, 2023

Study Completion Date

October 27, 2023

Conditions
Mediterranean FeverColchicine Resistance
Interventions
BIOLOGICAL

Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients.

"* Adherence to colchicine therapy will be assessed by the Girerd questionnaire (6 questions ) completed by the patient at the inclusion visit.~* A blood sample (8ml) is taken, including a haemogram, CRP and creatinine and proteinuria.~* Standard on-site stool analysis for C. difficile toxin.~For research purposes, samples of:~* Stool. If the patient is unable to produce stools on the day of the visit, a collection kit with 2 tubes containing a preservative will be given to him/her as well as a stamped envelope to take the sample at home and send it by post within 10 days according to a validated procedure.~* A strand of hair with the diameter of a pencil and a minimum length of 2 cm, in the region of the posterior vertex.~* In patients with baldness or bleached hair only: pubic and/or axillary hair, a pencil-sized strand.~* Additional blood (5ml) and urine (2ml) samples for colchicine determination."

Trial Locations (1)

75020

Service de Médecine Interne. Hôpital Tenon, 4 Rue de la Chine, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER